Knockdown of PTGS2 by CRISPR/CAS9 System Designates a New Potential Gene Target for Melanoma Treatment
CRISPR/Cas9 has become a powerful method to engineer genomes and to activate or to repress genes expression. As such, in cancer research CRISPR/Cas9 technology represents an efficient tool to dissect mechanisms of tumorigenesis and to discover novel targets for drug development. Here, we employed th...
Saved in:
Main Authors: | Giuseppe Ercolano (Author), Paola De Cicco (Author), Valentina Rubino (Author), Giuseppe Terrazzano (Author), Giuseppina Ruggiero (Author), Roberta Carriero (Author), Paolo Kunderfranco (Author), Angela Ianaro (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?
by: Giuseppe Terrazzano, et al.
Published: (2020) -
Insights on the Multifaceted Roles of Wild-Type and Mutated Superoxide Dismutase 1 in Amyotrophic Lateral Sclerosis Pathogenesis
by: Valentina Rubino, et al.
Published: (2023) -
Superoxide Dismutase-1 Intracellular Content in T Lymphocytes Associates with Increased Regulatory T Cell Level in Multiple Sclerosis Subjects Undergoing Immune-Modulating Treatment
by: Valentina Rubino, et al.
Published: (2021) -
Anti-metastatic Properties of Naproxen-HBTA in a Murine Model of Cutaneous Melanoma
by: Giuseppe Ercolano, et al.
Published: (2019) -
Specific knockdown of Htra2 by CRISPR-CasRx prevents acquired sensorineural hearing loss in mice
by: Yang Guo, et al.
Published: (2022)